Graduated at Faculty of Natural Science Zagreb (1997) and worked as an assistant at department of Electrochemistry, Faculty of Chemical engineering where did post graduate study. The topic of postgraduate study and master thesis was characterisation of surface (organic and inorganic) films on metallic surfaces. From 2002 joined PLIVA, pharmaceutical company where worked in the area of prefomulation, crystallisation, polymorph screening and solid state characterisation. The resent job position: project coordinator for the local and global projects in PLIVA which is now part of TEVA Pharmaceutical group.

Graduating from Bristol University in 1978 I joined The Wellcome Foundation at Dartford where I started working in their physical properties laboratory. Here I was introduced the thermal analytical techniques and solid state form issues. I became responsible for the sites X-ray powder diffraction facility, a then little used technique, and I raised the profile of the technique such that it became an integral part of the companies drug development process. I am a named co-inventor of a number of solid state forms of compounds and I have developed an expert knowledge of the solid state and contributed to the development of a number of X-ray enhancements. Following mergers with Glaxo and SmithKline Beecham I am now lead GlaxoSmithKline’s technical expert team for X-ray diffraction.

Sally, officially Sarah, Price trained as a theoretical chemist at the University of Cambridge, specialising in deriving models of the forces between molecules from their wavefunctions. She worked at the Universities of Chicago and Cambridge, before becoming a lecturer at University College London, where she is now a Professor specialising in Computational Chemistry. She is the Principal Investigator on a Research Councils UK Basic Technology project, "Control and Prediction of the Organic Solid State", www.cposs.org,uk which aims to develop a computational method of polymorph prediction. For her work on the computational modelling of polymorphism, she was awarded the 2005 Royal Society of Chemistry Industrially-Sponsored award in Statistical Mechanics and Simulation.

Chris Rielly is currently Head of the Chemical Engineering Department, having been appointed to chair at Loughborough University in 1999; prior to that was a lecturer at the University of Cambridge for 13 years. He obtained his PhD from Imperial College on two-phase mixing in stirred vessels and subsequently conducted post-doctoral research at Cambridge University Engineering Department on turbulent mixing of passive and reactive scalars. He has 25 years of experience working in experimental fluid mechanics and in particular on multi-phase flow and turbulent mixing within stirred chemical reactors. Current and recent research projects include particle image velocimetry in multi-phase stirred tank flows, CFD and population balance modelling of gas-liquid flows in stirred tanks, de-agglomeration and dispersion of formulated nano-particle products, direct nucleation control of pharmaceutical crystallisations, model based control and estimation of crystallization processes, spray freeze drying and spray drying of foods and pharmaceuticals.

I have five years experience in the pharmaceutical industry as a solid state chemist. Throughout this time I have designed and performed salt, cocrystal and polymorph screens, characterised and scaled up the hits from milligrams to tens of grams and developed processes to allow the physical forms to be reproducibly scaled by colleagues. My MSc in Chemical PR&D has given me an excellent grasp on the understanding of the impact of the solid state on product manufacture and performance; my experience scaling API to kilo gram quantities in the pilot plant has given acute awareness of issues that will have a large affect beyond the lab bench. Training as an organic chemist (BSc) and as a solid state chemist (MSc and five years on the job experience) I have a broad interdisciplinary knowledge of analytical techniques to include spectroscopy (NMR, IR, Raman) thermal analysis (DSC, TGA, Hot-stage microscopy), moisture sorption, X-ray diffraction and particle sizing. My current role in Chemical & Pharmaceutical Profiling (CPP) involves preformulation in addition to solid state chemistry.

Dr. Shawn (Xiaotian) Yin received his Ph. D. in Solid-State Chemistry from University of Waterloo, Canada. He then completed his Post Doctoral fellowship at Department of Materials Sciences and Engineering, Cornell University, U.S. Currently, Dr. Yin is a Principal Scientist and the group leader of Crystal Form Chemistry and Characterization group at Bristol-Myers Squibb Company. His research interests include pharmaceutical polymorphic form studies, pre-formulation/formulation work, API crystallization, nanomaterials for drug delivery, physical characterizations of pharmaceutical substances and powder X-ray diffraction applications in pharmaceutical sciences. Dr. Yin has (co)-authored 15 scientific publications and 8 patents. He serves as a scientific organization committee member for the Pharmaceutical Powder X-ray Diffraction Symposium. Dr. Yin is also a frequent invited lecturer at international and domestic scientific conferences and workshops.

Dr. Peter Karpinski is currently a leader of Salt and Polymorphism and Particle Engineering networks at Novartis Pharmaceuticals, US. His responsibilities include salt, co-crystal, and polymorphic form selection for API development, API characterization, crystal engineering, and optimization and scale up of the crystallization processes. Peter has over 35 years of international experience in both academic and industrial research on crystallization and precipitation processes. As an academician, he taught chemical engineering at Wroclaw University of Technology (Poland), Iowa State University (US), and Worcester Polytechnic Institute (US).

Prior to joining Novartis, as a scientist at Eastman Kodak and Sterling Drugs Co., Dr. Karpinski engineered new sub-micron and nano-crystalline imaging and pharmaceutical materials.

Peter has advised some 20 graduate students, and published several textbooks and over 50 papers. He also holds a number of patents, and serves as a referee for several journals devoted to crystallization and particulate technology.